Abbas, U. L., Hood, G., Wetzel, A. W., & Mellors, J. W. (2011). Factors influencing the emergence and spread of HIV drug resistance arising from rollout of antiretroviral pre-exposure prophylaxis PrEP. PloS One, 6, e18165. doi:10.1371/journal.pone.0018165.
CAS
Article
PubMed
PubMed Central
Google Scholar
Anderson, P. L., Glidden, D. V., Liu, A., Buchbinder, S., Lama, J. R., Guanira, J. V., et al. (2012). Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Science translational medicine, 4(151), 151ra125.
Azar, M. M., Springer, S. A., Meyer, J. P., & Altice, F. L. (2010). A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization. Drug and Alcohol Dependence, 112, 178–193. doi:10.1016/j.drugalcdep.2010.06.014.
Article
PubMed
PubMed Central
Google Scholar
Azar, P., Wood, E., Nguyen, P., Luma, M., Montaner, J., Kerr, T., & Milloy, M. J. (2015). Drug use patterns associated with risk of non-adherence to antiretroviral therapy among HIV-positive illicit drug users in a Canadian setting: A longitudinal analysis. BMC Infectious Diseases, 15, 193. doi:10.1186/s12879-015-0913-0.
Article
PubMed
PubMed Central
Google Scholar
Baeten, J. M., Donnell, D., Ndase, P., Mugo, N. R., Campbell, J. D., Wangisi, J., et al. (2012). Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. New England Journal of Medicine, 367, 399–410. doi:10.1056/NEJMoa1108524.
CAS
Article
PubMed
PubMed Central
Google Scholar
Brooks, R. A., Kaplan, R. L., Lieber, E., Landovitz, R. J., Lee, S. J., & Leibowitz, A. A. (2011). Motivators, concerns, and barriers to adoption of preexposure prophylaxis for HIV prevention among gay and bisexual men in HIV-serodiscordant male relationships. AIDS Care, 23, 1136–1145. doi:10.1080/09540121.2011.554528.
Article
PubMed
PubMed Central
Google Scholar
Brooks, R. A., Landovitz, R. J., Regan, R., Lee, S. J., & Allen Jr., V. C. (2015). Perceptions of and intentions to adopt HIV pre-exposure prophylaxis among black men who have sex with men in Los Angeles. International Journal of STD & AIDS, 26, 1040–1048. doi:10.1177/0956462415570159.
Article
Google Scholar
Carlo Hojilla, J., Koester, K. A., Cohen, S. E., Buchbinder, S., Ladzekpo, D., Matheson, T., & Liu, A. Y. (2016). Sexual behavior, risk compensation, and HIV prevention strategies among participants in the San Francisco PrEP Demonstration Project: A qualitative analysis of counseling notes. AIDS and Behavior, 20, 1461–1469. doi:10.1007/s10461-015-1055-5.
CAS
Article
PubMed
PubMed Central
Google Scholar
Cassell, M. M., Halperin, D. T., Shelton, J. D., & Stanton, D. (2006). Risk compensation: The Achilles’ heel of innovations in HIV prevention? BMJ (Clinical Research Ed.), 332, 605–607. doi:10.1136/bmj.332.7541.605.
Article
Google Scholar
Centers for Disease Control and Prevention. (2014). Preexposure prophylaxis for the prevention of HIV infection in the United States—2014. A Clinical Practice Guideline. Retrieved from http://www.cdc.gov/hiv/pdf/PrEPguidelines2014.pdf
Centers for Disease Control and Prevention. (2016). HIV Surveillance Report, 2015 (vol. 27). http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html. Accessed [October, 2017]
Corbin, J., & Strauss, A. (2008). Basics of qualitative research (3rd ed.). Thousand Oaks: Sage.
Google Scholar
Dawson, D. A. (2011). Defining risk drinking. Alcohol Research and Health, 34, 144–156.
PubMed
PubMed Central
Google Scholar
de Wit, J., Murphy, D., Lal, L., Audsley, J., Roth, N., Moore, R., … Wright, E. (2015). O19. 2 Pre-exposure prophylaxis and risk compensation: Evidence of decreased condom use at three-month follow-up among predominantly gay male participants in the VicPrEP study. Sexually Transmitted Infections, 91, A68-A68.
Donnell, D., Baeten, J. M., Bumpus, N. N., Brantley, J., Bangsberg, D. R., Haberer, J. E., et al. (2014). HIV protective efficacy and correlates of tenofovir blood concentrations in a clinical trial of PrEP for HIV prevention. Journal of Acquired Immune Deficiencies Syndrome, 66, 340–348. doi:10.1097/QAI.0000000000000172.
CAS
Article
Google Scholar
Ellis, R. J., Childers, M. E., Cherner, M., Lazzaretto, D., Letendre, S., Grant, I., & Group, H. I. V. N. R. C. (2003). Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy. Journal of Infectious Diseases, 188, 1820–1826. doi:10.1086/379894.
Article
PubMed
Google Scholar
Gibson, S., Crouch, P.-C., Hecht, J., Gagliano, J., Patriarca, T., Auerbach, J., … Hall, C. (2016). Eliminating barriers to increase uptake of PrEP in a community-based clinic in San Francisco. Paper presented at the International AIDS Conference, Durban, South Africa.
Golub, S. A., Kowalczyk, W., Weinberger, C. L., & Parsons, J. T. (2010). Preexposure prophylaxis and predicted condom use among high-risk men who have sex with men. Journal of Acquired Immune Deficiencies Syndrome, 54(5), 548–555. doi:10.1097/QAI.0b013e3181e19a54.
Article
Google Scholar
Grant, R. M., Anderson, P. L., McMahan, V., Liu, A., Amico, K. R., Mehrotra, M., et al. (2014). Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: A cohort study. The Lancet. Infectious Diseases, 14(9), 820–829. doi:10.1016/S1473-3099(14)70847-3.
Article
PubMed
Google Scholar
Grant, R. M., & Koester, K. A. (2016). What people want from sex and preexposure prophylaxis. Current Opinion in HIV and AIDS, 11(1), 3–9. doi:10.1097/COH.0000000000000216.
Article
PubMed
Google Scholar
Grant, R. M., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., … iPrEx Study, T (2010). Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New England Journal of Medicine, 363(27), 2587–2599. doi:http://dx.doi.org/10.1056/NEJMoa1011205
Haberer, J. E., Bangsberg, D. R., Baeten, J. M., Curran, K., Koechlin, F., Amico, K. R., et al. (2015). Defining success with HIV pre-exposure prophylaxis: A prevention-effective adherence paradigm. AIDS, 29, 1277–1285. doi:10.1097/QAD.0000000000000647.
Article
PubMed
PubMed Central
Google Scholar
Halkitis, P. N., Moeller, R. W., Siconolfi, D. E., Storholm, E. D., Solomon, T. M., & Bub, K. L. (2013). Measurement model exploring a syndemic in emerging adult gay and bisexual men. AIDS and Behavior, 17, 662–673. doi:10.1007/s10461-012-0273-3.
Article
PubMed
PubMed Central
Google Scholar
Hendershot, C. S., Stoner, S. A., Pantalone, D. W., & Simoni, J. M. (2009). Alcohol use and antiretroviral adherence: Review and meta-analysis. Journal of Acquired Immune Deficiencies Syndrome, 52, 180–202. doi:10.1097/QAI.0b013e3181b18b6e.
Article
Google Scholar
Hinkin, C. H., Barclay, T. R., Castellon, S. A., Levine, A. J., Durvasula, R. S., Marion, S. D., et al. (2007). Drug use and medication adherence among HIV-1 infected individuals. AIDS and Behavior, 11, 185–194. doi:10.1007/s10461-006-9152-0.
Article
PubMed
PubMed Central
Google Scholar
Hogben, M., & Liddon, N. (2008). Disinhibition and risk compensation: Scope, definitions, and perspective. Sexually Transmitted Diseases, 35, 1009–1010. doi:10.1097/OLQ.0b013e31818eb752.
Article
PubMed
Google Scholar
Humeniuk, R., Henry-Edwards, S., Ali, R., Poznyak, V., & Monteiro, M. G. (2010). The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST). Manual for use in primary care. Retrieved from Geneva, Switzerland: http://whqlibdoc.who.int/publications/2010/9789241599382_eng.pdf
Landovitz, R. J., Kofron, R., & McCauley, M. (2016). The promise and pitfalls of long-acting injectable agents for HIV prevention. Current Opinion in HIV and AIDS, 11(1), 122–128.
Liu, A. Y., Cohen, S. E., Vittinghoff, E., Anderson, P. L., Doblecki-Lewis, S., Bacon, O., et al. (2016). Preexposure prophylaxis for HIV infection integrated with municipal- and community-based sexual health services. JAMA Internal Medicine, 176, 75–84. doi:10.1001/jamainternmed.2015.4683.
Article
PubMed
PubMed Central
Google Scholar
Liu, A. Y., Vittinghoff, E., Chillag, K., Mayer, K., Thompson, M., Grohskopf, L., et al. (2013). Sexual risk behavior among HIV-uninfected men who have sex with men participating in a tenofovir preexposure prophylaxis randomized trial in the United States. Journal of Acquired Immune Deficiencies Syndrome, 64, 87–94. doi:10.1097/QAI.0b013e31828f097a.
CAS
Article
Google Scholar
Marcus, J. L., Glidden, D. V., Mayer, K. H., Liu, A. Y., Buchbinder, S. P., Amico, K. R., … Grant, R. M. (2013). No evidence of sexual risk compensation in the iPrEx trial of daily oral HIV preexposure prophylaxis. PLoS One, 8, e81997. doi:10.1371/journal.pone.0081997
McCormack, S., Dunn, D. T., Desai, M., Dolling, D. I., Gafos, M., Gilson, R., et al. (2016). Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): Effectiveness results from the pilot phase of a pragmatic open-label randomised trial. The Lancet, 387, 53–60. doi:10.1016/S0140-6736(15)00056-2.
Article
Google Scholar
Meyer, I. H. (2003). Prejudice, social stress, and mental health in lesbian, gay, and bisexual populations: Conceptual issues and research evidence. Psychological Bulletin, 129, 674–697. doi:10.1037/0033-2909.129.5.674.
Article
PubMed
PubMed Central
Google Scholar
Molina, J. M., Capitant, C., Spire, B., Pialoux, G., Cotte, L., Charreau, I., et al., Group, A. I. S. (2015). On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. New England Journal of Medicine, 373, 2237–2246. doi:10.1056/NEJMoa1506273.
Moore, D. J., Blackstone, K., Woods, S. P., Ellis, R. J., Atkinson, J. H., Heaton, R. K., et al., The Tmarc, G. (2012). Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence. AIDS Care, 24, 1504–1513. doi:10.1080/09540121.2012.672718.
Mugwanya, K. K., Donnell, D., Celum, C., Thomas, K. K., Ndase, P., Mugo, N., et al. (2013). Sexual behaviour of heterosexual men and women receiving antiretroviral pre-exposure prophylaxis for HIV prevention: A longitudinal analysis. The Lancet. Infectious Diseases, 13, 1021–1028. doi:10.1016/S1473-3099(13)70226-3.
Article
PubMed
PubMed Central
Google Scholar
National Institute on Drug Abuse. NIDA Quick Screen V1.0 and Questions 1–8 of the NIDA-Modified ASSIST V2.0. Retrieved from https://www.drugabuse.gov/sites/default/files/pdf/nmassist.pdf
Newcomb, M. E., Mongrella, M. C., Weis, B., McMillen, S. J., & Mustanski, B. (2016). Partner disclosure of PrEP use and undetectable viral load on geosocial networking apps: frequency of disclosure and decisions about condomless sex. JAIDS Journal of Acquired Immune Deficiency Syndromes, 71(2), 200–206.
Parker, S., Chan, P. A., Oldenburg, C. E., Hoffmann, M., Poceta, J., Harvey, J., et al. (2015). Patient experiences of men who have sex with men using pre-exposure prophylaxis to prevent HIV infection. AIDS Patient Care and STDs, 29, 639–642.
Article
PubMed
PubMed Central
Google Scholar
Perez-Figueroa, R. E., Kapadia, F., Barton, S. C., Eddy, J. A., & Halkitis, P. N. (2015). Acceptability of PrEP uptake among racially/ethnically diverse young men who have sex with men: The P18 study. AIDS Education and Prevention, 27, 112–125. doi:10.1521/aeap.2015.27.2.112.
Article
PubMed
PubMed Central
Google Scholar
Pines, H. A., Gorbach, P. M., Weiss, R. E., Shoptaw, S., Landovitz, R. J., Javanbakht, M., et al. (2014). Sexual risk trajectories among MSM in the United States: Implications for pre-exposure prophylaxis delivery. Journal of Acquired Immune Deficiencies Syndrome, 65, 579–586. doi:10.1097/QAI.0000000000000101.
Article
Google Scholar
Potter, W. J., & Levine-Donnerstein, D. (1999). Rethinking validity and reliability in content analysis. Journal of Applied Communication Research, 27(3), 258–284. doi:10.1080/00909889909365539.
Reback, C. J., Fletcher, J. B., Shoptaw, S., & Grella, C. E. (2013). Methamphetamine and other substance use trends among street-recruited men who have sex with men, from 2008 to 2011. Drug and Alcohol Dependence, 133, 262–265. doi:10.1016/j.drugalcdep.2013.06.007.
Article
PubMed
PubMed Central
Google Scholar
Shoptaw, S., & Reback, C. J. (2006). Associations between methamphetamine use and HIV among men who have sex with men: a model for guiding public policy. Journal of Urban Health, 83(6), 1151–1157.
Smith, D. K., Van Handel, M., Wolitski, R. J., Stryker, J. E., Hall, H. I., Prejean, J., et al. (2015). Vital signs: Estimated percentages and numbers of adults with indications for preexposure prophylaxis to prevent HIV acquisition—United States, 2015. MMWR Morbidity and Mortality Weekly Report, 64, 1291–1295. doi:10.15585/mmwr.mm6446a4.
Article
PubMed
Google Scholar
Storholm, E. D., Satre, D. D., Kapadia, F., & Halkitis, P. N. (2015). Depression, compulsive sexual behavior, and sexual risk-taking among urban young gay and bisexual men: The P18 Cohort Study [published online August 27, 2015]. Archives of Sexual Behavior. doi:10.1007/s10508-015-0566-5
U.S. Census Bureau. (2010). Bay Area Census: San Francisco City and County. Retrieved from February 2, 2017, from http://www.bayareacensus.ca.gov/counties/SanFranciscoCounty.htm
Volk, J. E., Marcus, J. L., Phengrasamy, T., Blechinger, D., Nguyen, D. P., Follansbee, S., & Hare, C. B. (2015). No new HIV infections with increasing use of HIV preexposure prophylaxis in a clinical practice setting. Clinical and Infectious Diseases, 61, 1601–1603. doi:10.1093/cid/civ778.
Article
Google Scholar
Vosburgh, H. W., Mansergh, G., Sullivan, P. S., & Purcell, D. W. (2012). A review of the literature on event-level substance use and sexual risk behavior among men who have sex with men. AIDS and Behavior, 16(6), 1394–1410.
Woolf, S. E., & Maisto, S. A. (2009). Alcohol use and risk of HIV infection among men who have sex with men. AIDS and Behavior, 13(4), 757–782.